Current and prospective treatments for multidrug-resistant gram-positive infections

Jeffrey M Rybak1, Katie E Barber, Michael J Rybak

  • 1University of Kentucky HealthCare, Department of Pharmacy , 800 Rose Street Room H110, Lexington KY 40536 , USA.

Abstract

Insights

Emerging resistance to antibiotics like vancomycin in Staphylococcus aureus and Enterococcus spp. necessitates exploring alternative therapies. New agents and optimized dosing are crucial for treating these nosocomial infections and preventing further resistance.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Staphylococcus aureus and Enterococcus spp. are leading causes of nosocomial infections with high mortality rates.
  • Increasing resistance to methicillin and vancomycin, and emerging resistance to linezolid and daptomycin, pose significant clinical challenges.

Purpose of the Study:

  • To review current and novel therapeutic strategies for resistant Gram-positive bacterial infections.
  • To discuss mechanisms of action, resistance, and clinical data for existing and emerging anti-infective agents.

Main Methods:

  • Review of in vitro and clinical data on currently available agents for resistant staphylococci and enterococci.
  • Discussion of novel combination regimens and prospective therapies like solithromycin, tedizolid, dalbavancin, and oritavancin.

Main Results:

  • Limited effectiveness of first-line agents due to rising resistance.
  • Emergence of reduced susceptibility to newer agents like linezolid and daptomycin.

Conclusions:

  • Alternative therapies including daptomycin, linezolid, ceftaroline, and novel anti-Gram-positive agents are increasingly significant due to vancomycin resistance and treatment failures.
  • Advancements in understanding antimicrobial pharmacokinetics-pharmacodynamics can improve patient outcomes and mitigate resistance development through optimized agent selection and dosing.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...